相关实验视频

Updated: Feb 28, 2026

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

高强度的Th1型NKT细胞激动剂通过规范限制设计作为免疫治疗剂

Yu Wen¹, Ye-Hui Wu¹, Qian-Nan Sun¹

¹International Joint Research Center for Intelligent Biosensing Technology and Health, National Key Laboratory of Green Pesticide, College of Chemistry, Central China Normal University, Wuhan 430079, China.

|February 27, 2026

概括

新的分支类型的α-galactosylceramide (αGalCer) 显示出强大的Th1-偏倚自然杀手T (NKT) 细胞激活. 这些新型激动剂显示出增强的抗瘤疗效和免疫治疗的转化潜力.

科学领域:

免疫学免疫学免疫学
药物发现药物发现药物发现
生物化学生物化学

背景情况:

自然杀手T (NKT) 细胞对于细胞免疫力对抗瘤和病原体至关重要.
开发强大的Th1-偏向NKT细胞激动剂,如α-galactosylceramide (αGalCer),对于免疫治疗至关重要.
之前对αGalCer的结构修改在增强Th1偏差反应方面取得了有限的成功.

研究的目的:

设计具有受限构造的新型αGalCer类似物,以增强NKT细胞激动性.
为了研究这些新类型的免疫治疗潜力.
评估新型激动剂对瘤的疗效.

主要方法:

通过将αGalCer的线性乙烯链替换为分支的图案来进行符合性限制策略.
一系列αGalCer分支类型的设计和合成.
在体内评估Th1偏差反应 (IFN-γ,IL-4) 和小鼠抗瘤疗效.
评估人类NKT细胞中的活性.

主要成果:

与αGalCer.相比,两个优化候选者GCB-27a和GCB-27b显示出显著增强的Th1偏差反应.
这些新型激动剂诱导的IFN-γ水平超过10倍,IL-4的产生有限.
在小鼠模型中,GCB-27a和GCB-27b表现出优越的抗瘤功效.
激动剂在人类NKT细胞中保持了显著的活性.

结论:

构造性限制策略成功产生了强大的Th1偏差NKT细胞激动剂.
GCB-27a和GCB-27b是具有转化潜力的有前途的免疫治疗药物.
这些发现为开发有效的NKT细胞基础免疫疗法提供了新的途径.

关键词:

这是一种NKT细胞激动剂.分支链链分支链链的分支链.构造上的限制构造上的限制葡萄糖类脂类化合物葡萄糖类脂类化合物免疫疗法免疫疗法 α-galactosylceramide 的使用情况.

更多相关视频

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

Published on: February 15, 2021

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cells of the Innate Immune Response

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...